Investing Profile

Chandra Leo

VCInvestorAdvisor

Biotech & Healthcare Investor

hbmpartners.comZurich, Switzerland

Your Intro Paths to Chandra Leo

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Chandra Leo on

Current Investing Position

Hbm Partners Partner

Investment Range

$10 - $25

Sweet Spot

$15

Investments On Record

6

Chandra Leo is on these Sector & Stage Rankings

Medical Devices (Series A)Investors who were founders BioTech (Series A)Investors who invested in female founders Investors who invested in diverse founders Medical Devices (Series B)Pharmaceuticals (Series A)BioTech (Series B)Diagnostics (Series A)Pharmaceuticals (Series B)Therapeutics (Series A)Therapeutics (Series B)Canada Digital Health (Series B)Diagnostics (Series B)Digital Health (Series A)

Chandra Leo's Investments On Record (5)

Company	StageDateRound Size	Total Raised
Dren Bio	Series BJun 2022$65M Series AOct 2020$60M	$130M
Co-investors: Sakae Asanuma (Taiho Ventures), Rajeev Dadoo (SR One), Andrew Schiff (Aisling Capital)
Monte Rosa Therapeutics	Series BSep 2020$96M	$220M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Markus Warmuth (Versant Ventures), Alexander Mayweg (Versant Ventures), Andrew Schiff (Aisling Capital)
Fore Biotherapeutics	Series CSep 2020$57M	$170M
Co-investors: Simeon J. George (SR One), Michal Silverberg (Novartis Venture Fund), Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Matthew Foy (SR One), Ran Nussbaum (Pontifax Venture Capital)
Turning Point Therapeutics	Series CMay 2017$45M	$130M
Co-investors: Carl Gordon (OrbiMed), Simeon J. George (SR One), Hongbo Lu (Vivo Capital)
ESBATech	Series BN/A

Investors who invest with Chandra Leo

Aisling Capital

Alexander Mayweg

Versant Ventures

New Enterprise Associates (NEA)